Experimental Oncology
  • Home
    • About edition
  • New issue
  • Archive
  • Author
  • Information for authors
  • Publications requirements
  • Actual information
  • Book review
  • Brief report
  • Case reports
  • Clinical experience
  • Digest
  • Editorial
  • Exchange of experience
  • Experimental research
  • History of oncology
  • Information
  • International experience
  • Lectures
  • Materials of scientific conferences
  • Official information
  • Opinion
  • Original investigations
  • Review
  • Supplements

    Ключевое слово :   hormonotherapy

    MODERN ASPECTS OF NEOADJUVANT POLYCHEMOTHERAPY IN TREATMENT OF PATIENTS WITH BREAST CANCER
    MODERN ASPECTS OF NEOADJUVANT POLYCHEMOTHERAPY IN TREATMENT OF PATIENTS WITH BREAST CANCER
    Authors:Sivak L.A. Lyalkin S.A. Maidanevich N.N. Askolsky A.V. ... №13 2 2011 10
    EVOLUTION OF CLINICAL PROBLEMS IN BREAST CANCER AND THE MODERN ONCOLOGY PROGRESS
    EVOLUTION OF CLINICAL PROBLEMS IN BREAST CANCER AND THE MODERN ONCOLOGY PROGRESS
    2019-04-04 6
    AROMASIN TREATMENT IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
    AROMASIN TREATMENT IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
    2019-04-04 4
    AROMASIN TREATMENT IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
    AROMASIN TREATMENT IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
    2019-04-04 5
    EVOLUTION OF CLINICAL PROBLEMS IN BREAST CANCER AND THE MODERN ONCOLOGY PROGRESS
    EVOLUTION OF CLINICAL PROBLEMS IN BREAST CANCER AND THE MODERN ONCOLOGY PROGRESS
    Authors:Bilynskyj B. №12 3 2010 2
    AROMASIN TREATMENT IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
    AROMASIN TREATMENT IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER
    Authors:Rusyn A.V. Rishko M.F. №12 1 2010 11
    FARESTON® (ТOREMIFENE): MULTIPLE EFFECTS IN PRE-CANCER AND CANCER
    FARESTON® (ТOREMIFENE): MULTIPLE EFFECTS IN PRE-CANCER AND CANCER
    №11 1 2009 4
    FARESTON® (ТOREMIFENE) DOSE OPTIMIZATION IN TREATMENT OF PATIENTS WITH LOCAL FORMS OF DISHORMONAL MAMMARY DYSPLASIAS DEPENDING ON THE RECEPTOR STATUS
    FARESTON® (ТOREMIFENE) DOSE OPTIMIZATION IN TREATMENT OF PATIENTS WITH LOCAL FORMS OF DISHORMONAL MAMMARY DYSPLASIAS DEPENDING ON THE RECEPTOR STATUS
    Authors:Shpon’ka I.S. Bondareva V.A. №10 4 2008 9
    ANTIANDROGENS IN HORMONOTHERAPY OF PROSTATE CANCER PATIENTS
    ANTIANDROGENS IN HORMONOTHERAPY OF PROSTATE CANCER PATIENTS
    №10 2 2008 7
    BREAST CANCER HORMONOTHERAPY: CURRENT STATUS OF THE PROBLEM
    BREAST CANCER HORMONOTHERAPY: CURRENT STATUS OF THE PROBLEM
    Authors:Tarutinov V.I. Kovaleva L.Yu. №9 2 2007 9
    12»
    Читаються за рейтингом

    REPLICATIVE STRESS PROTEINS AS POTENTIAL PROGNOSTIC MARKERS OF RECURRENCE...

    MARKERS OF BONE TISSUE REMODELING IN CARCINOGENESIS, TUMOR PROGRESSION AND...

    IMMUNOPHENOTYPIC PROFILE OF MALIGNANT B-LYMPHOCYTES OF PATIENTS WITH...

    THE INFLUENCE OF SPERMINE ON THE SURVIVAL AND ELECTROKINETIC CHARACTERISTICS...

    CURRENT STATE OF LABORATORY DIAGNOSIS OF MATURE B-CELL...

    Publisher MORION Apteka online Компендиум — справочник лекарств №1 Chasopys online Oncology

    «Morion» publishing house
    Editorial office and publisher: 02140, Kyiv, ave. Bazhana 10A
    Tel.: +380 (44) 585-97-10

    Specialized medical online edition for doctors,
    pharmacists, students of medical and pharmaceutical universities
    pharmaceutical universities. Disclaimer

    Publisher MORION Apteka online Компендиум Chasopys online Oncology